
Journal of International Obstetrics and Gynecology ›› 2022, Vol. 49 ›› Issue (6): 649-654.doi: 10.12280/gjfckx.20220244
• Obstetric Physiology & Obstetric Disease: Review • Previous Articles Next Articles
SONG Shuang, QIAO Chong
Received:2022-04-05
Published:2022-12-15
Online:2023-01-11
SONG Shuang, QIAO Chong. [J]. Journal of International Obstetrics and Gynecology, 2022, 49(6): 649-654.
Add to citation manager EndNote|Ris|BibTeX
| 指标 | 2分 | 1分 | 0分 |
|---|---|---|---|
| 胎儿水肿 | 无 | 心包积液或胸腹水 | 胎儿水肿 |
| 心/胸面积比 | 心胸面积比0.25~0.35 | >0.35~0.5 | <0.25或>0.5 |
| 心脏功能 | 瓣膜无返流 | 三尖瓣返流 | 二尖瓣返流 |
| 脐动脉血流频谱 | 正常 | 舒张期血流消失 | 舒张期血流反向 |
| 静脉导管频谱 | 正常 | a波反向 | a波消失 |
| 指标 | 2分 | 1分 | 0分 |
|---|---|---|---|
| 胎儿水肿 | 无 | 心包积液或胸腹水 | 胎儿水肿 |
| 心/胸面积比 | 心胸面积比0.25~0.35 | >0.35~0.5 | <0.25或>0.5 |
| 心脏功能 | 瓣膜无返流 | 三尖瓣返流 | 二尖瓣返流 |
| 脐动脉血流频谱 | 正常 | 舒张期血流消失 | 舒张期血流反向 |
| 静脉导管频谱 | 正常 | a波反向 | a波消失 |
| [1] |
Alsaied T, Baskar S, Fares M, et al. First-Line Antiarrhythmic Transplacental Treatment for Fetal Tachyarrhythmia: A Systematic Review and Meta-Analysis[J]. J Am Heart Assoc, 2017, 6(12):e007164. doi: 10.1161/JAHA.117.007164.
doi: 10.1161/JAHA.117.007164 |
| [2] |
Yuan SM. Fetal Arrhythmias: Genetic Background and Clinical Implications[J]. Pediatr Cardiol, 2019, 40(2):247-256. doi: 10.1007/s00246-018-2008-3.
doi: 10.1007/s00246-018-2008-3 |
| [3] |
Huhta JC. Fetal congestive heart failure[J]. Semin Fetal Neonatal Med, 2005, 10(6):542-552. doi:10.1016/j.siny.2005.08.005.
doi: 10.1016/j.siny.2005.08.005 |
| [4] |
Miyoshi T, Hosoda H, Kurosaki KI, et al. Plasma natriuretic peptide levels reflect the status of the heart failure in fetuses with arrhythmia[J]. J Matern Fetal Neonatal Med, 2021, 34(12):1883-1889. doi: 10.1080/14767058.2019.1651271.
doi: 10.1080/14767058.2019.1651271 |
| [5] |
张文, 朱琦, 陈娇, 等. 心血管整体评分在胎儿心律失常中的价值[J]. 中国临床医学影像杂志, 2019, 30(1):12-14,31. doi: 10.12117/jccmi.2019.01.004.
doi: 10.12117/jccmi.2019.01.004 |
| [6] |
Carvalho JS. Fetal dysrhythmias[J]. Best Pract Res Clin Obstet Gynaecol, 2019, 58:28-41. doi: 10.1016/j.bpobgyn.2019.01.002.
doi: S1521-6934(18)30262-1 pmid: 30738635 |
| [7] | Freeman RK, Garite TJ, Nageotte MP, et al. Fetal heart rate monitoring[M]. Fourth edition. Lippincott Williams & Wilkins, 2012. |
| [8] |
Veduta A, Panaitescu AM, Ciobanu AM, et al. Treatment of Fetal Arrhythmias[J]. J Clin Med, 2021, 10(11):2510. doi: 10.3390/jcm10112510.
doi: 10.3390/jcm10112510 |
| [9] |
Demirci O, Tosun Ö, Bolat G. Prenatal diagnosis and management of fetal supraventricular tachyarrhythmia and postnatal outcomes[J]. J Gynecol Obstet Hum Reprod, 2022, 51(3):102323. doi: 10.1016/j.jogoh.2022.102323.
doi: 10.1016/j.jogoh.2022.102323 |
| [10] |
Izmirly P, Kim M, Friedman DM, et al. Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers[J]. J Am Coll Cardiol, 2020, 76(3):292-302. doi: 10.1016/j.jacc.2020.05.045.
doi: S0735-1097(20)35402-4 pmid: 32674792 |
| [11] |
Strand S, Strasburger JF, Lutter WJ, et al. Repolarization Predictors of Fetal Long QT Syndrome[J]. Heart Rhythm O2, 2020, 1(3):200-205. doi: 10.1016/j.hroo.2020.05.003.
doi: 10.1016/j.hroo.2020.05.003 pmid: 33543149 |
| [12] |
Sharp A, Patient C, Pickett J, et al. Pregnancy-related inappropriate sinus tachycardia: A cohort analysis of maternal and fetal outcomes[J]. Obstet Med, 2021, 14(4):230-234. doi: 10.1177/1753495X21990196.
doi: 10.1177/1753495X21990196 |
| [13] |
Wacker-Gussmann A, Strasburger JF, Wakai RT. Contribution of Fetal Magnetocardiography to Diagnosis, Risk Assessment, and Treatment of Fetal Arrhythmia[J]. J Am Heart Assoc, 2022, 11(15):e025224. doi: 10.1161/JAHA.121.025224.
doi: 10.1161/JAHA.121.025224 |
| [14] |
Glickstein JS, Buyon J, Friedman D. Pulsed Doppler echocardiographic assessment of the fetal PR interval[J]. Am J Cardiol, 2000, 86(2):236-239. doi: 10.1016/s0002-9149(00)00867-5.
doi: 10.1016/s0002-9149(00)00867-5 pmid: 10913494 |
| [15] |
Hansahiranwadee W. Diagnosis and Management of Fetal Autoimmune Atrioventricular Block[J]. Int J Womens Health, 2020, 12:633-639. doi: 10.2147/IJWH.S257407.
doi: 10.2147/IJWH.S257407 pmid: 32884363 |
| [16] |
Tugcu AU, Ince DA, Esin S, et al. Complete Fetal Atrioventricular Block Associated with Maternal Autoinflammatory Diseases: Case Report and Literature Review[J]. Acta Cardiol Sin, 2020, 36(1):72-75. doi: 10.6515/ACS.202001_36(1).20190711A.
doi: 10.6515/ACS.202001_36(1).20190711A pmid: 31903011 |
| [17] |
Jaeggi ET, Silverman ED, Laskin C, et al. Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses[J]. J Am Coll Cardiol, 2011, 57(13):1487-1492. doi: 10.1016/j.jacc.2010.12.014.
doi: 10.1016/j.jacc.2010.12.014 pmid: 21435519 |
| [18] |
Kang SL, Howe D, Coleman M, et al. Foetal supraventricular tachycardia with hydrops fetalis: a role for direct intraperitoneal amiodarone[J] Cardiol Young, 2015, 25(3):447-453. doi: 10.1017/S104795111400002X.
doi: 10.1017/S104795111400002X |
| [19] |
张慧婧, 杨慧霞. 胎儿心律失常的宫内治疗现状[J]. 中华围产医学杂志, 2021, 24(4):241-244. doi: 10.3760/cma.j.cn113903-20210315-00214.
doi: 10.3760/cma.j.cn113903-20210315-00214 |
| [20] |
Miyoshi T, Maeno Y, Hamasaki T, et al. Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial[J]. J Am Coll Cardiol, 2019, 74(7):874-885. doi: 10.1016/j.jacc.2019.06.024.
doi: 10.1016/j.jacc.2019.06.024 |
| [21] |
Sridharan S, Sullivan I, Tomek V, et al. Flecainide versus digoxin for fetal supraventricular tachycardia: Comparison of two drug treatment protocols[J]. Heart Rhythm, 2016, 13(9):1913-1919. doi: 10.1016/j.hrthm.2016.03.023.
doi: 10.1016/j.hrthm.2016.03.023 pmid: 27554948 |
| [22] |
Strizek B, Berg C, Gottschalk I, et al. High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia[J]. Heart Rhythm, 2016, 13(6):1283-1288. doi: 10.1016/j.hrthm.2016.01.029.
doi: 10.1016/j.hrthm.2016.01.029 pmid: 26829115 |
| [23] |
Ekiz A, Kaya B, Bornaun H, et al. Flecainide as first-line treatment for fetal supraventricular tachycardia[J]. J Matern Fetal Neonatal Med, 2018, 31(4):407-412. doi: 10.1080/14767058.2017.1286317.
doi: 10.1080/14767058.2017.1286317 pmid: 28114840 |
| [24] |
Uzun O, Babaoglu K, Sinha A, et al. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment[J]. Cardiol Young, 2012, 22(4):372-380. doi: 10.1017/S1047951111001272.
doi: 10.1017/S1047951111001272 pmid: 22008551 |
| [25] |
Ekman-Joelsson BM, Mellander M, Lagnefeldt L, et al. Foetal tachyarrhythmia treatment remains challenging even if the vast majority of cases have a favourable outcome[J]. Acta Paediatr, 2015, 104(11):1090-1097. doi:10.1111/apa.13111.
doi: 10.1111/apa.13111 |
| [26] |
Zaidi SJ, Siddiqui S, Cuneo BF, et al. Prenatal diagnosis and management of junctional ectopic tachycardia[J]. HeartRhythm Case Rep, 2017, 3(11):503-508. doi: 10.1016/j.hrcr.2017.07.022.
doi: 10.1016/j.hrcr.2017.07.022 pmid: 29387539 |
| [27] |
Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus[J]. Circulation, 2012, 126(1):76-82. doi: 10.1161/CIRCULATIONAHA.111.089268.
doi: 10.1161/CIRCULATIONAHA.111.089268 pmid: 22626746 |
| [28] |
Hutter D, Silverman ED, Jaeggi ET. The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review[J]. Scand J Immunol, 2010, 72(3):235-241. doi: 10.1111/j.1365-3083.2010.02440.x.
doi: 10.1111/j.1365-3083.2010.02440.x pmid: 20696021 |
| [29] |
Ruffatti A, Cerutti A, Favaro M, et al. Plasmapheresis, intravenous immunoglobulins and bethametasone - a combined protocol to treat autoimmune congenital heart block: a prospective cohort study[J]. Clin Exp Rheumatol, 2016, 34(4):706-713.
pmid: 27385463 |
| [1] | WANG Xin-yi, SUN Li-zhou, JIANG Zi-yan. A Case of Late Pregnancy Complicated with Congenital Factor Ⅺ Deficiency [J]. Journal of International Obstetrics and Gynecology, 2026, 53(3): 267-269. |
| [2] | ZHENG Xiao-lin, WEI Fang. Research Progress on LPCAT1 in Gynecological Malignancies [J]. Journal of International Obstetrics and Gynecology, 2026, 53(3): 273-277. |
| [3] | XIANG Xiao-ying, SUN Ya-ge, ZHANG Yun-feng, JIA Han, WANG Yue. Research Advances in the Immune Microenvironment and Immunotherapy for p53-Abnormal Endometrial Carcinoma [J]. Journal of International Obstetrics and Gynecology, 2026, 53(3): 285-291. |
| [4] | WU Hua-tuo, HUANG Chun-lin, MA Yan, GE Ting, LI Li. Research Progress on the Immune Microenvironment of Ovarian Cancer [J]. Journal of International Obstetrics and Gynecology, 2026, 53(3): 297-301. |
| [5] | ZHENG Le, ZHANG Xin, JIA Hai-qing. A Case Report of Pulmonary Metastasis from Placental Site Trophoblastic Tumor Treated with Chemotherapy Combined with Thoracoscopic Surgery [J]. Journal of International Obstetrics and Gynecology, 2026, 53(3): 302-305. |
| [6] | YIN Di-shuang, LI Nan, GUO Hong-xia. Collision Tumor Composed of High-Grade Endometrial Stromal Sarcoma and Endometrioid Adenocarcinoma: A Case Report [J]. Journal of International Obstetrics and Gynecology, 2026, 53(3): 311-317. |
| [7] | LIU Er-yu, REN Qing-yu, GAO Xiang. A Case of Recurrent Cervical Cancer with Vesicoenteric Fistula [J]. Journal of International Obstetrics and Gynecology, 2026, 53(3): 322-328. |
| [8] | YANG Yan, YAN Kai, ZHOU Deng-lian, DENG Xin. Exosomes in Endometrial Fibrosis: Mechanisms and Potential Diagnostic and Therapeutic Applications [J]. Journal of International Obstetrics and Gynecology, 2026, 53(3): 335-340. |
| [9] | XIAO Jin-fen, ZHANG Xu-mei, LIU Yi, ZENG Qian, ZHANG Wen-ying. Impaired β-hCG Clearance Due to End-Stage Renal Disease: A Case Report [J]. Journal of International Obstetrics and Gynecology, 2026, 53(3): 357-360. |
| [10] | LIU Meng-ting, YAO Shun, DING Jin. Research Progress on Mesenchymal Stem Cell Therapy for Stress Urinary Incontinence [J]. Journal of International Obstetrics and Gynecology, 2026, 53(2): 121-124. |
| [11] | ZHANG Chun-jie, WU Li-xian, YANG Bo, LIU Zhi-jie, ZHENG Jing. A Case of Atypical McCune-Albright Syndrome in A Prepubertal Girl [J]. Journal of International Obstetrics and Gynecology, 2026, 53(2): 150-152. |
| [12] | XU Meng-ting, LU Di, SONG Dian-rong. Research Progress in the Tumor Microenvironment of Ovarian Cancer [J]. Journal of International Obstetrics and Gynecology, 2026, 53(2): 188-193. |
| [13] | ZHANG Yan, SONG Shu-fang. Advances in the Application of DNA Methylation in Cervical Lesions [J]. Journal of International Obstetrics and Gynecology, 2026, 53(2): 206-210. |
| [14] | FU Hai-yu, SHEN Shi-yin, CHEN Ruo-bing, YUAN Shuo, HUANG Shao-ya. Acute Hyponatremia Complicated Epilepsy Following Cisplatin Chemotherapy for Cervical Squamous Cell Carcinoma: A Case Report [J]. Journal of International Obstetrics and Gynecology, 2026, 53(2): 220-223. |
| [15] | LIU Ya-xin, BAI Ru-xue, GUO Duan-yue, PENG Yong-pai. A Case Report of Advanced Recurrent Cervical Cancer with Renal Failure Treated with Cadonilimab Combined with Chemotherapy and Bevacizumab [J]. Journal of International Obstetrics and Gynecology, 2026, 53(2): 223-227. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||